[HTML][HTML] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, A Mariandyshev, B Shrestha, N Lukhele… - Pulmonology, 2021 - Elsevier
Abstract The World Health Organization (WHO) recommends countries introduce new anti-
TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to …
TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to …
[PDF][PDF] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, S Borisov, E Danila, A Mariandyshev… - 2021 - repository.ubn.ru.nl
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, S Borisov, E Danila, A Mariandyshev… - …, 2021 - eprints.uanl.mx
Of 383 patients treated with bedaquiline but not delamanid, 284 (74.2%) achieved treatment
success, while 25 (6.5%) died, 11 (2.9%) failed and 63 (16.5%) were lost to follow-up.© …
success, while 25 (6.5%) died, 11 (2.9%) failed and 63 (16.5%) were lost to follow-up.© …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, S Borisov, E Danila… - …, 2021 - pubmed.ncbi.nlm.nih.gov
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, S Borisov, E Danila, A Mariandyshev… - …, 2021 - research.rug.nl
Abstract The World Health Organization (WHO) recommends countries introduce new anti-
TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to …
TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: results from a large global cohort
S Koirala, S Borisov, E Danila, A Mariandyshev… - …, 2021 - epublications.vu.lt
Of 383 patients treated with bedaquiline but not delamanid, 284 (74.2%) achieved treatment
success, while 25 (6.5%) died, 11 (2.9%) failed and 63 (16.5%) were lost to follow-up.© …
success, while 25 (6.5%) died, 11 (2.9%) failed and 63 (16.5%) were lost to follow-up.© …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, S Borisov, E Danila, A Mariandyshev… - PULMONOLOGY, 2021 - iris.unibs.it
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, S Borisov, E Danila, A Mariandyshev… - …, 2021 - cris.unibo.it
Abstract The World Health Organization (WHO) recommends countries introduce new anti-
TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to …
TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.
S Koirala, S Borisov, E Danila, A Mariandyshev… - …, 2021 - europepmc.org
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.
S Koirala, S Borisov, E Danila, A Mariandyshev… - …, 2021 - qmro.qmul.ac.uk
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …
in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively …